Abstract

Results of the Myeloproliferative Neoplasms - Research Consortium (MPN-RC) 112 Randomized Trial of Pegylated Interferon Alfa-2a (PEG) Versus Hydroxyurea (HU) Therapy for the Treatment of High Risk Polycythemia Vera (PV) and High Risk Essential Thrombocythemia (ET)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Worldwide Examination of Patients with CLL Hospitalized for COVID-19
... Ana Muntañola Prat
Blood | VOL. 136
, et. al. ... Ana Muntañola Prat
05 Nov 2020
Spleen and Symptom Responses with Fedratinib (FEDR) in Patients with Myelofibrosis (MF) and Substantial Splenomegaly
Jean-Jacques Kiladjian ... Animesh Pardanani
Blood | VOL. 138
Jean-Jacques Kiladjian, et. al.Jean-Jacques Kiladjian ... Animesh Pardanani
05 Nov 2021
Pelabresib (CPI-0610) Monotherapy in Patients with Myelofibrosis - Update of Clinical and Translational Data from the Ongoing Manifest Trial
Marina Kremyanskaya ...
Blood | VOL. 138
Marina Kremyanskaya, et. al.Marina Kremyanskaya ...
05 Nov 2021
Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients with Hematologic Malignancies
Naveen Pemmaraju ...
Blood | VOL. 138
Naveen Pemmaraju, et. al.Naveen Pemmaraju ...
05 Nov 2021
View more papers

More From: Blood

Paper Title
Journal
Date
Author
IFN-I promotes T cell-independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD.
Shan Su ... Karina Yazdanbakhsh
Blood | VOL. -
Shan Su, et. al.Shan Su ... Karina Yazdanbakhsh
10 Dec 2024
An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA.
Carlo Castruccio Castracani ... Stefano Rivella
Blood | VOL. -
Carlo Castruccio Castracani, et. al.Carlo Castruccio Castracani ... Stefano Rivella
10 Dec 2024
Inflammation-driven NFκB signaling represses Ferroportin transcription in macrophages via HDAC 1 and 3.
Oriana Marques ... Martina U Muckenthaler
Blood | VOL. -
Oriana Marques, et. al.Oriana Marques ... Martina U Muckenthaler
10 Dec 2024
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes.
Jacqueline S Garcia ... Guillermo Garcia-Manero
Blood | VOL. -
Jacqueline S Garcia, et. al.Jacqueline S Garcia ... Guillermo Garcia-Manero
09 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.